Baker Bros. Advisors »

Celcuity shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.8M 536k 14.57
2023-09-30 $4.9M 536k 9.14

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Mirati Therapeutics
Immunocore Holdings Ads (IMCR)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Invitae Corporation Notes 1.5% 4/1/2028 (Principal)
Abcellera Biologics (ABCL)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Entrada Therapeutics (TRDA)
Ultragenyx Pharmaceutical (RARE)

View all positions for Baker Bros. Advisors

Top funds holding Celcuity

Soleus Capital Management
VR Adviser
Commodore Capital
Perceptive Advisors
NEA Management Company
Vanguard Group
Captrust Financial Advisors
Baker Bros. Advisors
Partner Fund Management
J. Goldman & Co
Punch & Associates Investment Management
Gagnon Securities
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management

View all funds holding Celcuity